Decreased transplant-related complications and improved leukemia-free survival in adults receiving methotrexate combined with cyclosporin compared with either agent alone for prevention of graft-versus-host disease. Advisory Committee of the International Bone Marrow Transplant Registry.
Ringdén
O
O
Department of Clinical Immunology, Karolinska Institute, Huddinge Hospital, Sweden.
D000328:Adult; D016026:Bone Marrow Transplantation / Q000276:immunology*; D002648:Child; D016572:Cyclosporine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006086:Graft vs Host Disease / Q000276:immunology / Q000517:prevention & control*; D006801:Humans; D007938:Leukemia / Q000601:surgery*; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use*; D011336:Probability; D016016:Proportional Hazards Models; D012044:Regression Analysis
D016572:Cyclosporine; D008727:Methotrexate